drugset / Trial / NCT00426478

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

NCT00426478

Phase 4 Completed 80 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

A double-blind, active-controlled, randomized trial to compare Valsartan plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5 mg. Study design: 2 weeks washout, 8 weeks treatment period.

Timeline

Start
2006-11
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Hydrochlorothiazide Unknown 12.5 mg
Subject Valsartan Small molecule 80 mg